Skip to content

Redox status and antioxidant response in professional cyclists during training.

PMID 24803271 (2014): taper, tapering — Time-trial performance (study note for endurance athletes).

Last updated/Feb 23, 2026, 11:13 PM

Study note • PMID 24803271

Redox status and antioxidant response in professional cyclists during training.

European journal of sport science2014 • DOI 10.1080/17461391.2014.915345
Evidence C58/100
Action 2: Consider

Worth trying if it fits your goal and context.

ELI5

In plain language

The aim of this study was to investigate whether different phases of training affect oxidative stress and antioxidant defences in professional cyclists. (controlled study; well-trained cyclists).

The abstract doesn’t indicate a clear change in Time-trial performance under the tested conditions. Treat this as a signal, not a guarantee; confirm methods and context in the full paper.

Takeaways

What the abstract suggests

  • Study question: The aim of this study was to investigate whether different phases of training affect oxidative stress and antioxidant defences in professional cyclists.
  • The abstract doesn’t indicate a clear change in Time-trial performance under the tested conditions.
  • Population: well-trained cyclists.
  • Protocol cues (title/abstract): 1000 mg • 400 mg.

Protocol

Protocol (as reported)

  • Intervention/exposure: taper, tapering.
  • Dose/time/duration cues in abstract/title: 1000 mg • 400 mg.
  • Outcomes: Time-trial performance.
  • Replication note: abstracts often omit adherence and timing; confirm details before changing training or supplementation.

Fit

Who it helps, and who should skip it

Who it helps

  • Athletes similar to the study population (well-trained cyclists) working on tapering.
  • Athletes who can measure Time-trial performance with a repeatable workout or time-trial effort.

Who should skip

  • If you have symptoms or conditions that make the intervention risky, get professional guidance.
  • If you’re near race day and can’t safely test, defer the experiment.

Methods

What the study actually did

  • Design: controlled study.
  • Population: well-trained cyclists.
  • Outcomes measured: Time-trial performance.
  • Protocol cues mentioned: 1000 mg • 400 mg.
  • Source: PubMed PMID 24803271 (2014) — European journal of sport science.

Results excerpt

What the abstract reports

Plasma ORAC, LPO and 8-OHdG were similar in both groups of athletes.

Note: excerpts are short; for full context, read the paper.

Limits

Limitations & bias

  • Abstract-only summaries can miss critical details (population, protocol, adherence, and context).
  • Single studies often don’t generalize to your event, history, and training load; treat results as a starting point.
  • If your context differs (elite vs recreational; cycling vs running), adjust expectations and be conservative.
  • This is performance information, not medical advice.

Coaching beta

Get a plan that adapts to your life.

Join the 26weeks.ai TestFlight beta for adaptive coaching, recovery-aware adjustments, and race-week reminders.

Keep going

Sources